|
Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury
|
journal
|
January 2009 |
|
Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?
|
journal
|
February 2010 |
|
Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity
|
journal
|
August 2013 |
|
Quantification of cells cultured on 96-well plates
|
journal
|
October 1989 |
|
Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture
|
journal
|
December 2008 |
|
Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs
|
journal
|
July 2011 |
|
What do I need to know about immunoglobulin light chain (AL) amyloidosis?
|
journal
|
July 2012 |
|
Thermodynamic Instability of Human λ6 Light Chains: Correlation with Fibrillogenicity †
|
journal
|
October 1999 |
|
Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture
|
journal
|
November 2010 |
|
An in vitro model of light chain deposition disease
|
journal
|
March 2009 |
|
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
|
journal
|
January 2012 |
|
Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes
|
journal
|
February 2013 |
|
p38 Kinase Is Activated in the Alzheimer's Disease Brain
|
journal
|
May 1999 |
|
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture
|
journal
|
February 2004 |
|
Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38 MAPK pathway
|
journal
|
February 2010 |
|
In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides
|
journal
|
August 2011 |
|
A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro
|
journal
|
July 2000 |
|
A role for destabilizing amino acid replacements in light-chain amyloidosis.
|
journal
|
June 1994 |
|
Cell lysis with dimethyl sulphoxide produces stable homogeneous solutions in the dichlorofluorescein oxidative stress assay
|
journal
|
January 2008 |
|
The Mitochondrial Uncoupling Agent 2,4-Dinitrophenol Improves Mitochondrial Function, Attenuates Oxidative Damage, and Increases White Matter Sparing in the Contused Spinal Cord
|
journal
|
October 2004 |
|
The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein
|
journal
|
July 2006 |
|
Mutational and genetic determinants of λ6 light chain amyloidogenesis
|
journal
|
October 2013 |
|
Amyloid diseases of the heart: assessment, diagnosis, and referral
|
journal
|
December 2010 |
|
Systemic Amyloidoses
|
journal
|
June 2013 |
|
Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells
|
journal
|
January 2007 |
|
Current perspectives on cardiac amyloidosis
|
journal
|
February 2012 |
|
Infusion of Light Chains From Patients With Cardiac Amyloidosis Causes Diastolic Dysfunction in Isolated Mouse Hearts
|
journal
|
October 2001 |
|
Diagnosis and Management of the Cardiac Amyloidoses
|
journal
|
September 2005 |
|
Cardiac Amyloidosis
|
journal
|
September 2012 |
|
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL
|
journal
|
May 2006 |
|
TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells
|
journal
|
February 2014 |
|
Amyloidosis: Pathogenesis and New Therapeutic Options
|
journal
|
May 2011 |
|
Amyloid heart disease
|
journal
|
February 2010 |
|
AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils
|
journal
|
December 2012 |
|
Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit
|
journal
|
January 2003 |
|
Synaptotoxic Amyloid-β Oligomers: A Molecular Basis for the Cause, Diagnosis, and Treatment of Alzheimer's Disease?
|
journal
|
December 2012 |
|
Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vλ6 proteins
|
journal
|
June 2004 |
|
Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury
|
journal
|
January 2009 |
|
Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?
|
journal
|
February 2010 |
|
Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity
|
journal
|
August 2013 |
|
Quantification of cells cultured on 96-well plates
|
journal
|
October 1989 |
|
A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescin-diacetate
|
journal
|
November 1992 |
|
Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture
|
journal
|
December 2008 |
|
Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs
|
journal
|
July 2011 |
|
What do I need to know about immunoglobulin light chain (AL) amyloidosis?
|
journal
|
July 2012 |
|
Systemic and microvascular oxidative stress induced by light chain amyloidosis
|
journal
|
November 2010 |
|
Thermodynamic and Kinetic Characterization of a Germ Line Human λ6 Light-Chain Protein: The Relation between Unfolding and Fibrillogenesis
|
journal
|
March 2009 |
|
Novel cell lines derived from adult human ventricular cardiomyocytes
|
journal
|
July 2005 |
|
Thermodynamic Instability of Human λ6 Light Chains: Correlation with Fibrillogenicity †
|
journal
|
October 1999 |
|
Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture
|
journal
|
November 2010 |
|
An in vitro model of light chain deposition disease
|
journal
|
March 2009 |
|
Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns
|
journal
|
March 2004 |
|
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
|
journal
|
January 2012 |
|
Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes
|
journal
|
February 2013 |
|
p38 Kinase Is Activated in the Alzheimer's Disease Brain
|
journal
|
May 1999 |
|
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture
|
journal
|
February 2004 |
|
Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38 MAPK pathway
|
journal
|
February 2010 |
|
In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides
|
journal
|
August 2011 |
|
A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro
|
journal
|
July 2000 |
|
Thermodynamic Modulation of Light Chain Amyloid Fibril Formation
|
journal
|
January 2000 |
|
Cell lysis with dimethyl sulphoxide produces stable homogeneous solutions in the dichlorofluorescein oxidative stress assay
|
journal
|
January 2008 |
|
The Mitochondrial Uncoupling Agent 2,4-Dinitrophenol Improves Mitochondrial Function, Attenuates Oxidative Damage, and Increases White Matter Sparing in the Contused Spinal Cord
|
journal
|
October 2004 |
|
The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein
|
journal
|
July 2006 |
|
Mutational and genetic determinants of λ6 light chain amyloidogenesis
|
journal
|
October 2013 |
|
Comparison of the effect of a mitochondrial uncoupler, 2,4-dinitrophenol and adrenaline on oxygen radical production in the isolated perfused rat liver
|
journal
|
June 1992 |
|
Amyloid diseases of the heart: assessment, diagnosis, and referral
|
journal
|
December 2010 |
|
Systemic Amyloidoses
|
journal
|
June 2013 |
|
Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells
|
journal
|
January 2007 |
|
Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins
|
journal
|
December 2011 |
|
Current perspectives on cardiac amyloidosis
|
journal
|
February 2012 |
|
Human Amyloidogenic Light Chains Directly Impair Cardiomyocyte Function Through an Increase in Cellular Oxidant Stress
|
journal
|
April 2004 |
|
Diagnosis and Management of the Cardiac Amyloidoses
|
journal
|
September 2005 |
|
Cardiac Amyloidosis
|
journal
|
September 2012 |
|
Infusion of Light Chains From Patients With Cardiac Amyloidosis Causes Diastolic Dysfunction in Isolated Mouse Hearts
|
journal
|
October 2001 |
|
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL
|
journal
|
May 2006 |
|
Radioimmunodetection of amyloid deposits in patients with AL amyloidosis
|
journal
|
September 2010 |
|
TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells
|
journal
|
February 2014 |
|
Amyloidosis: Pathogenesis and New Therapeutic Options
|
journal
|
May 2011 |
|
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
|
journal
|
May 2008 |
|
Amyloid heart disease
|
journal
|
February 2010 |
|
AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils
|
journal
|
December 2012 |
|
Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit
|
journal
|
January 2003 |
|
The diagnosis and typing of cardiac amyloidosis
|
journal
|
January 2003 |
|
Synaptotoxic Amyloid-β Oligomers: A Molecular Basis for the Cause, Diagnosis, and Treatment of Alzheimer's Disease?
|
journal
|
December 2012 |